CSIR launches India’s first anti diabetic ayurvedic drug BGR -34
Posted on:28 Jun 2016 11:06:20
28 June 2016 Current Affairs: The Council for Scientific and Industrial Research (CSIR) has launched BGR-34, an anti-diabetic ayurvedic drug designed for type 2 Diabetes mellitus.
The anti-diabetic ayurvedic drug BGR-34 has been jointly developedby National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP).
BGR-34 : BGR-34 works by controlling blood sugar and limiting the harmful effects and toxicity of other drugs. It contains 34 identified active phyto-constitutes from herbal resources. It has been economically priced at 5 rupees per tablet as compared to latest DPP4 inhibitors globally.
Council of Scientific and Industrial Research (CSIR) : CSIR is an autonomous body and the largest research and development (R&D) organisation in India. It was established in 1942. It operates as an autonomous body registered under the Registration of Societies Act of 1860.
It is mainly funded by the Union Ministry of Science and Technology. CSIR’s R&D activities include aerospace engineering, ocean sciences, structural engineering, metallurgy, life sciences, chemicals, mining, food, petroleum, leather, and environment.
FreshersLive - No.1 Job site in India. Fresherslive Current Affairs 2017 section offers informative quiz questions with answers regarding latest current affairs today for all sorts of competitive exams like UPSC, TNPSC , IFS, IAS, IPS, railway exams (RRB) and banking exams like IPBS PO, IPBS clerk, Federal Bank PO, ICICI, SBI, RBI legal officer & Grade officer posts and much more. Register with us to get latest Current Affairs Updates. Also get latest Current Affairs news and quiz Updates for free alerts daily through E-mail